Antineoplastic AgentsDoxorubicinAntineoplastic Agents, PhytogenicLeukemia P388Amaryllidaceae AlkaloidsDrug Screening Assays, AntitumorNarcissusEllipticinesAntibiotics, AntineoplasticCyclophosphamideBibenzylsAntineoplastic Combined Chemotherapy ProtocolsEtoposideBryostatinsAntineoplastic Agents, AlkylatingThiadiazinesBleomycinCisplatinTumor Cells, CulturedDaunorubicinPaclitaxelDrug SynergismAncitabineNeoplasms6-MercaptopurineGalliumMethotrexateDrug ResistanceCell SurvivalDepsipeptidesCell Line, TumorApoptosisLeukemia L1210Sarcoma 180Drug Resistance, NeoplasmAminoacridinesEpothilonesDose-Response Relationship, DrugMolecular StructureLomustineDrug Administration ScheduleLactonesFluorouracilAntimetabolites, AntineoplasticVinca AlkaloidsDrug EvaluationCell DivisionVinblastineXenograft Model Antitumor AssaysDrug Evaluation, PreclinicalLung NeoplasmsProdrugsCamptothecinCell CycleNeoplasms, ExperimentalMacrolidesP-GlycoproteinTime FactorsDrug Resistance, MultipleNeoplasm TransplantationHL-60 CellsMice, NudeTreatment OutcomeCell ProliferationClinical Trials as TopicEnzyme InhibitorsStilbenesLymphoma, Non-HodgkinDrug InteractionsLeukemiaCombined Modality TherapyCytarabineAntibodies, Monoclonal, Murine-DerivedVincristineBreast NeoplasmsKineticsCell LineAsparaginaseIsoquinolinesBiotransformationPrednisoloneLymphoma, Large B-Cell, DiffuseOvarian NeoplasmsColonic NeoplasmsDNA DamageMelphalanStereoisomerismRhabdomyosarcomaPrecursor Cell Lymphoblastic Leukemia-LymphomaIfosfamideTaxoidsDexamethasoneCaspasesRemission InductionDacarbazineCarmustineRNA, MessengerStructure-Activity RelationshipDNAHodgkin Disease